InterCure Ltd. (NASDAQ:INCR - Get Free Report) saw a large increase in short interest in May. As of May 31st, there was short interest totalling 16,500 shares, an increase of 26.9% from the May 15th total of 13,000 shares. Currently, 0.1% of the company's shares are sold short. Based on an average daily trading volume, of 12,900 shares, the days-to-cover ratio is currently 1.3 days.
Hedge Funds Weigh In On InterCure
An institutional investor recently bought a new position in InterCure stock. Moore Capital Management LP purchased a new stake in InterCure Ltd. (NASDAQ:INCR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 97,273 shares of the company's stock, valued at approximately $156,000. Moore Capital Management LP owned about 0.21% of InterCure as of its most recent SEC filing. Institutional investors own 8.34% of the company's stock.
InterCure Stock Up 1.3%
NASDAQ:INCR traded up $0.02 during trading hours on Friday, hitting $1.52. The company had a trading volume of 20,297 shares, compared to its average volume of 26,295. InterCure has a 1 year low of $1.17 and a 1 year high of $2.62. The company has a 50-day moving average of $1.51 and a 200 day moving average of $1.54. The company has a quick ratio of 1.18, a current ratio of 1.73 and a debt-to-equity ratio of 0.34.
InterCure Company Profile
(
Get Free Report)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Stories
Before you consider InterCure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.
While InterCure currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
